Company / Capital Expenditures
IDEAYA Biosciences, Inc. Capital Expenditures History
FY2017-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Capital Expenditures
$2.4M
FY2025
5-year range
$493.0K / $3.9M
FY2021-FY2025
Trend
-38.6%
vs FY2024
Sector context
#93 of 194
Health Care
What the data says
At $2M, IDEAYA Biosciences, Inc.'s capital expenditures ranks #93 of 194 in the Health Care sector. Capital Expenditures has fluctuated over the past 9 years, ranging from $493,000 in FY2022 to $4M in FY2024.
Based on SEC 10-K filings.
$2M in FY2025 with a 5-year CAGR of +6.8%.
Remained stable around $2M over the past 2 years.
Health Care sector context is included.
Capital Expenditures over time
Growth rates
- 3-Year CAGR
- +68.7%
- 5-Year CAGR
- +6.8%
- 10-Year CAGR
- -
Sector benchmark
#93 of 194 in Health CareTop 48% of 194This company $2.4M Sector average $117.5M
▼
-98.0% below sector average
Key checks
Key Insights
- 5-year CAGR of +6.8%, indicating consistent growth.
- In FY2025, capital expenditures decreased 38.6% year-over-year.
- Ranks #93 out of 194 companies in the Health Care sector.
- Peak capital expenditures was recorded in FY2024.
Company context
Key Data Points
- Altman Z-Score 4.55 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Capital ExpendituresValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $2.4M | -38.6% |
| FY2024 | $3.9M | +62.9% |
| FY2023 | $2.4M | +380.3% |
| FY2022 | $493.0K | -63.6% |
| FY2021 | $1.4M | -20.8% |
| FY2020 | $1.7M | +26.2% |
| FY2019 | $1.4M | -20.8% |
| FY2018 | $1.7M | -2.8% |
| FY2017 | $1.8M | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026